McLaren Oakland earns national accreditation from the Commission on Cancer

The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) has granted Three-Year Accreditation to the cancer program at McLaren Oakland. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.     

Because it is a CoC-accredited cancer center, McLaren Oakland takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists.  This multidisciplinary partnership results in improved patient care.  

“The quality standards established by the Commission on Cancer ensure an exceptional level of cancer care for patients,” says Chad M. Grant, President and CEO of McLaren Oakland. “This accreditation of our cancer program validates that we have a caring and compassionate team of experts to help coordinate care and help improve the quality of lives of our patients.” 

The CoC Accreditation Program provides the framework for McLaren Oakland to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of-life care.  When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling, and patient centered services including psycho-social support, a patient navigation process, and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.  

Like all CoC-accredited facilities, McLaren Oakland maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society (ACS).  This nationwide oncology outcomes database is the largest clinical disease registry in the world.  Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care.  CoC-accredited cancer centers, in turn, have access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports.  These reports help CoC facilities with their quality improvement efforts.  

ACS estimates that more than 1.6 million cases of cancer will be diagnosed in 2013.  There are currently more than 1,500 CoC-accredited cancer programs in the U.S.  and Puerto Rico, representing 30 percent of all hospitals.  CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients.  When cancer patients choose to seek care locally at a CoC-accredited cancer center, they are gaining access to comprehensive, state-of-the-art cancer care close to home. The CoC provides the public with information on the resources, services, and cancer treatment experience for each CoC-accredited cancer program through the CoC Hospital Locator at http://www.facs.org/cancerprogram/index.html.

Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care.  Its membership includes Fellows of the American College of Surgeons.  For more information, visit: www.facs.org/cancer

About McLaren Oakland
McLaren Oakland is a 328-bed medical center that provides primary and specialty healthcare services to the greater Pontiac and Oakland County community. Founded in 1953, McLaren Oakland has grown to a full-fledged medical community that includes more than 300 physicians, an inpatient hospital with a range of services including cardiovascular care, cancer services, women’s health, minimally invasive robotic surgery, comprehensive orthopedic services, and a state-of-the-art Surgery Center. McLaren Oakland is also a verified trauma center and an accredited stroke center. To learn more, visit www.mclaren.org/Oakland 

About McLaren Health Care
McLaren Health Care, headquartered in Flint, Mich., is a fully integrated health network committed to quality evidence-based patient care and cost efficiency. The McLaren system includes 12 hospitals, ambulatory surgery centers, imaging centers, the state’s only proton therapy center, an employed primary care physician network, commercial and Medicaid HMOs covering more than 250,000 lives, home health and hospice providers, durable medical equipment services, retail pharmacy services, and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by Karmanos Cancer Institute, one of only two National Cancer Institute-designated centers in the state. McLaren has 21,000 employees and more than 20,000 network physicians. Its operations are housed in more than 300 facilities serving a 54-county market and 75 percent of Michigan’s population. Learn more at mclaren.org